NCT00154609

Brief Summary

We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat. The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2002

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
Last Updated

January 23, 2006

Status Verified

January 1, 2002

First QC Date

September 9, 2005

Last Update Submit

January 20, 2006

Conditions

Osteoporosis

Outcome Measures

Primary Outcomes (1)

  • The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.

Interventions

Gu-Sui-Bu (Davallia Divaricata)DRUG

Eligibility Criteria

Age45 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal osteoporosis

You may not qualify if:

  • Insulin dependent diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Medical Center

Taipei, 7, Chung-Shan South Road, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Osteoporosis

Interventions

gu-sui-bu

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Liu Hwa-Chang, Ph.D

    National Taiwan University Medical Center

    STUDY CHAIR

Central Study Contacts

Liu Hwa-Chang, Ph.D

CONTACT

886-2-23956988hcliu@ha.mc.ntu.edu.tw

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 12, 2005

Study Start

January 1, 2002

Last Updated

January 23, 2006

Record last verified: 2002-01

Locations

TW(1)